FY24 is anticipated to be a turning point for hospital companies in India – earnings are poised to rise more than 17 percent over the next...
The Indian healthcare sector in FY23 recorded the highest-ever private capital deal flow in the last decade, making it more significant given the muted macroeconomic environment....
Covid-19 pandemic brought the need for health sciences companies and healthcare service providers to fast track their digital transformation journeys. The venture funding for digital health...
Healthcare digital transformation is entering the deep-water zone. New digital technologies, such as 5G, fifth-generation fixed network (F5G), AI, IoT, and cloud computing, are combined with...
Growth seems to be eluding the diagnostics chains in India. The post-Covid growth for the base business is currently 6–10 percent on a two-year CAGR basis,...
The Union Budget is round the corner. The industry is expecting a dedicated institute for research on medical devices, NIMER. Production-linked incentive scheme is expected to...
As we usher in 2023, surgeries at hospitals are close to the pre-pandemic levels with a resurgence in non-Covid admissions. While Q4 FY2022 had witnessed a...
With the Indian healthcare delivery market poised for ₹5.6 trillion by the end of FY23, at a 15–17-percent CAGR, to reach ₹7.67 trillion in FY25, and...
With 5G services launched in select cities on October 1, and plans for pan India soon, Indian healthcare is poised for a disruption in patient care...
Despite the enormous and unimaginable loss of life and livelihood, now that the end of Covid-19 pandemic is finally in sight, the global disruption presents an...
Semiconductors, and their integrated circuits, act as the brain for millions of medical devices – about 50 percent have a semiconductor. However, these once inexpensive and...
Hospitals seem structurally well placed with expectations of a normal Q1FY23 to be driven by higher in-patient volume and, thus, higher in-patient conversion. One important lever...
The Indian diagnostics market, pegged at ₹67,830 crore in 2021, is projected to reach ₹112,700 crore by 2025, growing at a 14-percent CAGR. With heightened competition...
With the abatement of the pandemic, there is a rebound in businesses of healthcare. Procedures and routine testings have returned. CapEx plans too are back on...
As we usher in FY23, continued growth in healthcare needs is expected, with part of the pent-up demand and price increases driving growth. The National Health...
Anju Arora is the founder and managing director of ADI Media Private Limited, a business-to-business (B2B) information provider. ADI Media’s B2B products include Medical Buyer, Communications Today, Broadcast & CableSat, and TV Veopar Journal.
She is an Economics Honors graduate from Lady Shri Ram College, New Delhi and PGDP from Indian Institute of Foreign Trade. She has also participated in the OPM Key Executives Program at Harvard Business School.
Anju Arora is also the co-founder and executive director on the Board of ADI BPO Services Limited, the majority shareholder in MPS Limited, listed on all the major India stock exchanges and a Macmillan company till 2011.
Copyright © 2024 Medical Buyer maintained by Fullstack development